Literature DB >> 20380968

Hydrocephalus after aneurysmal subarachnoid hemorrhage.

Anand V Germanwala1, Judy Huang, Rafael J Tamargo.   

Abstract

Hydrocephalus is a common and potentially devastating complication of aneurysmal subarachnoid hemorrhage (SAH). Its incidence is approximately 20% to 30%, and its onset can be acute, within 48 hours after SAH, or rarely chronic, occurring in a delayed fashion weeks and even months after the hemorrhage. Early recognition of its signs and symptoms and accurate interpretation of computed tomography (CT) studies are important for the management of patients with SAH. Clinically, a poor neurologic grade has the highest correlation with an increased incidence of hydrocephalus. Radiographically, the bicaudate index on CT studies has emerged as the best marker of this condition. Although further studies are needed to understand the complex pathophysiology of this condition, hydrocephalus after SAH can be treated effectively using current technology. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20380968     DOI: 10.1016/j.nec.2009.10.013

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  17 in total

Review 1.  Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans DeVries; Merel J A Luitse; Marinus Vermeulen; Gabriel J E Rinkel; W Peter Vandertop; Yvo B Roos
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

2.  Lumbar catheter for monitoring of intracranial pressure in patients with post-hemorrhagic communicating hydrocephalus.

Authors:  Verena Speck; Dimitre Staykov; Hagen B Huttner; Roland Sauer; Stefan Schwab; Juergen Bardutzky
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

3.  Acute Brain Injury after Subarachnoid Hemorrhage.

Authors:  Yusuke Egashira; Guohua Xi; Neeraj Chaudhary; Ya Hua; Aditya S Pandey
Journal:  World Neurosurg       Date:  2015-05-06       Impact factor: 2.104

4.  Non-adjustable gravitational valves or adjustable valves in the treatment of hydrocephalus after aneurysmal subarachnoid hemorrhage patients?

Authors:  Sebastian Arts; Jasper Hans van Lieshout; Martine van Bilsen; Cihat Karadag; Thomas Beez; Leonie van den Abbeele; Rene Aquarius; Saman Vinke; Ronald H M A Bartels; Erik J van Lindert; Daniel Hänggi; Hieronymus D Boogaarts
Journal:  Acta Neurochir (Wien)       Date:  2022-09-23       Impact factor: 2.816

5.  Nuclear factor κB activation impairs ependymal ciliogenesis and links neuroinflammation to hydrocephalus formation.

Authors:  Michael Lattke; Alexander Magnutzki; Paul Walther; Thomas Wirth; Bernd Baumann
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

6.  Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.

Authors:  Andreas H Kramer; Derek J Roberts; Jessalyn Holodinsky; Stephanie Todd; Michael D Hill; David A Zygun; Peter Faris; John H Wong
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

7.  Multi-omic analysis elucidates the genetic basis of hydrocephalus.

Authors:  Andrew T Hale; Lisa Bastarache; Diego M Morales; John C Wellons; David D Limbrick; Eric R Gamazon
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.423

8.  Permanent cerebrospinal fluid diversion in subarachnoid hemorrhage: Influence of physician practice style.

Authors:  Domenic P Esposito; Fernando D Goldenberg; Jeffrey I Frank; Agnieszka A Ardelt; Ben Z Roitberg
Journal:  Surg Neurol Int       Date:  2011-08-30

Review 9.  The Pathogenesis of Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lu-Ting Kuo; Abel Po-Hao Huang
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

10.  Chronic hydrocephalus after experimental subarachnoid hemorrhage.

Authors:  Peter Lackner; Alexander Vahmjanin; Qin Hu; Paul R Krafft; William Rolland; John H Zhang
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.